US2016058707A1PendingUtilityA1
Novel formulation of diclofenac
Est. expiryApr 24, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 9/10A61P 25/06A61P 29/00A61P 27/02A61K 9/143A61K 9/513A61K 31/196A61K 9/4825A61K 9/146A61P 15/08A61K 9/0053A61K 9/0087A61K 9/4858Y10T428/2982A61K 9/1682A61K 9/4808A61K 9/145A61P 11/06A61K 9/5123A61K 9/16A61K 9/5115A61K 47/20A61P 17/14A61K 9/5192A61K 9/14A61K 9/5138A61P 15/00A61K 47/12A61K 9/141A61P 17/06Y02A50/30
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.
Claims
exact text as granted — not AI-modified1 . A method for producing a composition, comprising the steps of:
dry milling a solid biologically active material and a millable grinding matrix in a mill comprising a plurality of milling bodies, for a time period sufficient to produce particles of the biologically active material dispersed in an at least partially milled grinding material, wherein the biologically active material is diclofenac.
2 .- 41 . (canceled)Join the waitlist — get patent alerts
Track US2016058707A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.